Please assess the completion status of the following clinical trial:

Trial Title: Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~The Test Group will be patients with rheumatoid arthritis, newly starting therapy with etanercept (Enbrel). Inclusion criteria for the exposed cohort subjects are:~* Patients aged 18 years and over at the time of diagnosis;~* Patients from the BSRBR with moderate RA as defined by a DAS28 (\>3.2 and ≤5.1);~* Patients who have given informed consent for long term follow-up and access to all medical records;~* Patients initiating (i.e. at leats one treatment) treatment with etanercept (Enbrel) for RA.~The Control Group:~* Patients aged 18 years and over a the time of diagnosis;~* Patients from the BSRBR with moderate RA as defined by a DAS28 (\>3.2 and ≤5.1);~* Patients who have given informed consent for long term follow-up and access to all medical records; Patients are receiving at least one traditional DMARD and have never been prescribed a biologic agent;~Exclusion Criteria:~Per BSRBR registry since data is retropsectively being analyzed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Biologic (Type: None): None
- non-biologic DMARD (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).